Fund performance: OrbiMed, Canaan, DCM head the SFERS early-decade venture portfolioByMark Boslet24 October 2017•2 mins readJavaScript is required to read this article. Please enable it in your browser and reload the page.FeaturedFundraisingInvestorsManagersFundraisingInvestor PerformancePensionsPerformance
